BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 22609126)

  • 1. Direct measurement of the time-dependent mechanical response of HPMC and PEO compacts during swelling.
    Hewlett KO; L'Hote-Gaston J; Radler M; Shull KR
    Int J Pharm; 2012 Sep; 434(1-2):494-501. PubMed ID: 22609126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquisolid compacts: the effect of cosolvent and HPMC on theophylline release.
    Nokhodchi A; Aliakbar R; Desai S; Javadzadeh Y
    Colloids Surf B Biointerfaces; 2010 Aug; 79(1):262-9. PubMed ID: 20451361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The suitability of tris(hydroxylmethyl) aminomethane (THAM) as a buffering system for hydroxypropyl methylcellulose (HPMC) hydrophilic matrices containing a weak acid drug.
    Pygall SR; Kujawinski S; Timmins P; Melia CD
    Int J Pharm; 2010 Mar; 387(1-2):93-102. PubMed ID: 20005935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High molecular weight polyethylene oxides (PEOs) as an alternative to HPMC in controlled release dosage forms.
    Maggi L; Bruni R; Conte U
    Int J Pharm; 2000 Feb; 195(1-2):229-38. PubMed ID: 10675700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting drug release from hydroxypropyl methylcellulose matrix systems in the light of classical and percolation theories.
    Caraballo I
    Expert Opin Drug Deliv; 2010 Nov; 7(11):1291-301. PubMed ID: 20977292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified release from hydroxypropyl methylcellulose compression-coated tablets.
    Rujivipat S; Bodmeier R
    Int J Pharm; 2010 Dec; 402(1-2):72-7. PubMed ID: 20883759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behaviour of HPMC compacts investigated using UV-imaging.
    Pajander J; Baldursdottir S; Rantanen J; Ostergaard J
    Int J Pharm; 2012 May; 427(2):345-53. PubMed ID: 22387216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a controlled release low dose class II drug-Glipizide.
    Jamzad S; Fassihi R
    Int J Pharm; 2006 Apr; 312(1-2):24-32. PubMed ID: 16481135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
    Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designing HPMC matrices with improved resistance to dissolved sugar.
    Williams HD; Ward R; Culy A; Hardy IJ; Melia CD
    Int J Pharm; 2010 Nov; 401(1-2):51-9. PubMed ID: 20858538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synchrotron X-ray microtomographic study of tablet swelling.
    Laity PR; Cameron RE
    Eur J Pharm Biopharm; 2010 Jun; 75(2):263-76. PubMed ID: 20172028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of critical polymer properties for polymer release and swelling of HPMC matrix tablets.
    Viridén A; Wittgren B; Larsson A
    Eur J Pharm Sci; 2009 Feb; 36(2-3):297-309. PubMed ID: 19038336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of swelling of hydrophilic polymer matrix tablets by ultrasound techniques.
    Leskinen JT; Hakulinen MA; Kuosmanen M; Ketolainen J; Abrahmsén-Alami S; Lappalainen R
    Int J Pharm; 2011 Feb; 404(1-2):142-7. PubMed ID: 21094229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial studies of water granulation of eight grades of hypromellose (HPMC).
    Herder J; Adolfsson A; Larsson A
    Int J Pharm; 2006 Apr; 313(1-2):57-65. PubMed ID: 16510256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Properties of HPMC:PEO Extended Release Hydrophilic Matrices and their Response to Ionic Environments.
    Hu A; Chen C; Mantle MD; Wolf B; Gladden LF; Rajabi-Siahboomi A; Missaghi S; Mason L; Melia CD
    Pharm Res; 2017 May; 34(5):941-956. PubMed ID: 27633887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thin-coating as an alternative approach to improve flow properties of ibuprofen powder.
    Genina N; Räikkönen H; Ehlers H; Heinämäki J; Veski P; Yliruusi J
    Int J Pharm; 2010 Mar; 387(1-2):65-70. PubMed ID: 20005929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evaluation of pluronic F127-based controlled-release ocular delivery systems for pilocarpine.
    Desai SD; Blanchard J
    J Pharm Sci; 1998 Feb; 87(2):226-30. PubMed ID: 9519158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-processing of hydroxypropyl methylcellulose (HPMC) for improved aqueous dispersibility.
    Sharma P; Modi SR; Bansal AK
    Int J Pharm; 2015 May; 485(1-2):348-56. PubMed ID: 25796127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hildebrand solubility parameter to predict drug release from hydroxypropyl methylcellulose gels.
    Bustamante P; Navarro-Lupión J; Peña MA; Escalera B
    Int J Pharm; 2011 Jul; 414(1-2):125-30. PubMed ID: 21620938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The physicodynamic properties of mucoadhesive polymeric films developed as female controlled drug delivery system.
    Yoo JW; Dharmala K; Lee CH
    Int J Pharm; 2006 Feb; 309(1-2):139-45. PubMed ID: 16376036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.